Addex to Present at the Swiss Biotech Day 2024
GlobeNewswire
*Geneva, Switzerland, April 19, 2024 - *Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company..
*Geneva, Switzerland, April 19, 2024 - *Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company..
Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson's disease treatments. The..
· *Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated..